Home > Insider Trading > Filing (0000899243-20-003371)

Filing Details

Accession Number:: 0000899243-20-003371
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-05 18:02:04
Reporting Period:: 2020-02-03

Accepted Time:: 2020-02-05 18:02:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1701541	Black Diamond Therapeutics Inc.	BDTX	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1687880	Versant Venture Capital Vi, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1745960	Versant Voyageurs I, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1745961	Versant Voyageurs I Parallel, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No
1765253	Versant Vantage I, L.p.	One Sansome Street Suite 3630 San Francisco CA 94104	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-03	4,973,787	$0.00	5,305,372	No	4	C	Direct
Common Stock	Acquisiton	2020-02-03	380,817	$0.00	380,817	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	1,277,111	$0.00	1,277,111	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	653,412	$0.00	5,958,784	No	4	C	Direct
Common Stock	Acquisiton	2020-02-03	150,085	$0.00	530,902	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	503,327	$0.00	1,780,438	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	454,548	$0.00	6,413,332	No	4	C	Direct
Common Stock	Acquisiton	2020-02-03	104,407	$0.00	635,309	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	350,141	$0.00	2,130,579	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	810,522	$0.00	810,522	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	79,013	$19.00	2,209,592	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	23,560	$19.00	658,869	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-02-03	396,082	$19.00	6,809,414	No	4	P	Direct
Common Stock	Acquisiton	2020-02-03	396,081	$19.00	1,206,603	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Direct
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Direct
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Direct
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2020-02-03	15,000,000	$0.00	4,973,787	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-02-03	1,148,474	$0.00	380,817	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-02-03	3,851,526	$0.00	1,277,111	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-02-03	1,970,572	$0.00	653,412	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-02-03	452,630	$0.00	150,085	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-02-03	1,517,940	$0.00	503,327	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-02-03	1,370,833	$0.00	454,548	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-02-03	314,873	$0.00	104,407	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-02-03	1,055,960	$0.00	350,141	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-02-03	2,444,382	$0.00	810,522	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date.
Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Bradley J. Bolzon is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Shares held by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel"). Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP LP") is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. is the general partner of Versant Voyageurs I GP LP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP. Bradley J. Bolzon, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Shares held by Versant Voyageurs I, L.P.("Versant Voyageurs I"). Versant Voyageurs I GP Company ("Versant Voyageurs I GP") is the general partner of Versant Voyageurs I. Bradley J. Bolzon is may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date.
Upon the closing of the Issuer's initial public offering, all shares of Series C Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series C Preferred Stock had no expiration date.
Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP LP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP GP") is the general partner of Versant Vantage I GP L.P. Bradley J. Bolzon is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Bradley J. Bolzon is a director of the Issuer and, accordingly, files separate Section 16 reports.
On February 3, 2020, Versant Voyageurs I purchased 79,013 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
On February 3, 2020, Versant I Parallel purchased 23,560 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
On February 3, 2020, Versant VI purchased 396,082 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
On February 3, 2020, Versant Vantage I purchased 396,081 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.